Pfizer Inc .
Pfizer is one step closer to getting children a Covid-19 shot. The company and its partner BioNTech SE said Monday their two-shot vaccine was found to be safe in children ages 5-to-11 years old in a late-stage study and generated a strong immune response in them. Pfizer will seek emergency use authorization in the U.S. as early as the end of the month. Pfizer shares rose 0.7% Monday.